Drug Shortage Report for SODIUM CHLORIDE BACTERIOSTATIC INJ

Last updated on 2025-05-02

Report ID 255312
Drug Identification Number 00402249
Brand name SODIUM CHLORIDE BACTERIOSTATIC INJ
Common or Proper name SODIUM CHLORIDE BACTERIOSTATIC INJECTION 0.9%
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) SODIUM CHLORIDE
Strength(s) 9MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 30 mL vial / fiole
ATC code V07AB
ATC description ALL OTHER NON-THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-07-01
Actual start date
Estimated end date 2025-07-31
Actual end date
Shortage status Anticipated shortage
Updated date 2025-05-02
Company comments We are currently collaborating with Health Canada’s Drug Shortages Unit to mitigate any market impact. Product on allocation.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-05-02 French Compare
v4 2025-05-02 English Compare
v3 2025-04-22 English Compare
v2 2025-04-21 French Compare
v1 2025-04-21 English Compare

Showing 1 to 5 of 5